Evidence map›Paper›PMID 42109508›Full record

ArticleFrontiers in allergy2026

Actual use of PROMs in asthma and rhinitis recommended by guidelines in clinical settings: PROMUSE respiratory study.

Ivan Cherrez-Ojeda, Jean Bousquet, Torsten Zuberbier, Juan C Calderon, Pavel Kolkhir, Anastasiia Allenova, Andrey Allenov, Sergey Tkachenko, Florin Mihaltan, Ruxandra Ulmeanu and 19 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Ivan Cherrez-OjedaInstitute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Jean BousquetInstitute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Torsten ZuberbierInstitute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Juan C CalderonUniversidad Espíritu Santo, Samborondón, Ecuador.
Pavel KolkhirInstitute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Anastasiia AllenovaLaboratory of Immune-Mediated Skin Diseases, Institute of Regenerative Medicine, Biomedical Science and Technology Park, First Moscow State Medical University Named After I.M. Sechenov (Sechenov University), Moscow, Russia.
Andrey AllenovInstitute for Leadership and Health Management, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Sergey TkachenkoRussian Medical Academy of Сontinuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russia.
Florin MihaltanNational Institute of Pneumology M Nasta, Bucharest, Romania.
Ruxandra UlmeanuIntegrated Pneumology and Bronchoscopy Center of Nord Pipera Hospital - Bucharest, Faculty of Medicine, Oradea, Romania.
Mona Al-AhmadDepartment of Microbiology, College of Medicine, University of Kuwait, Kuwait City, Kuwait.
Mònica Rodriguez-GonzálezPediatric Allergy and Clinical Immunology, Hospital Español de México, Ciudad de México, Mexico.
Guillermo Wakida-KusunokiColegio Mexicano de Pediatras Especialistas en Inmunología Clínica y Alergia, Mexico City, México.
German D RamonHospital Italiano Regional del Sur, Bahía Blanca, Argentina.
Maia RukhadzeFaculty of Medicine, Center Allergy & Immunology, Tbilisi, Georgia/Geomedi University, Tbilisi, Georgia.
Désirée E Larenas-LinnemannCenter of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, Mexico City, Mexico.
Mitja KošnikUniversity Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia.
Juan Carlos IvancevichServicio de Alergia e Immunologia Clinica Santa Isabel, Buenos Aires, Argentina.
Luis Felipe EnsinaDivision of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil.
Nelson A Rosario FilhoUrticaria Center of Reference and Excellence (UCARE), Department of Pediatrics, Federal University of Parana, Curitiba, Brazil.
Violeta KvedarieneInstitute of Biomedical Sciences, Department of Pathology, Faculty of Medicine, Vilnius University, and Institute of Clinical Medicine, Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine, Vilnius, Lithuania.
Herberto Jose Chong-NetoDepartment of Pediatrics, Hospital de Clínicas, Federal University of Paraná (UFPR), Curitiba, Brazil.
Ivan TinocoCentro de Alergia Tinoco, Machala, Ecuador.
Anna BedbrookMASK-air SAS, Montpellier, France.
Gabriela Rodas-ValeroUniversidad Espíritu Santo, Samborondón, Ecuador.
Marco Faytong-HaroFacultad de Investigación, Universidad Estatal de Milagro, Milagro, Guayas, Ecuador.
Marcus MaurerInstitute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Oliver PfaarDepartment of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
Karla Robles-VelascoUniversidad Espíritu Santo, Samborondón, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rationale: Guidelines advise for the implementation of patient-reported outcomes (PROMs) to provide crucial insights into patients' perceptions of their disease burden, treatment needs, and quality of life. Despite their proven benefits in managing chronic respiratory diseases like asthma, allergic rhinitis (AR), and rhinosinusitis (RS), there is limited data on their adoption among physicians treating these conditions. Objectives: Our objective is to identify the utilization patterns of PROMs, together with the reasons for their usage and the barriers to their adoption among practitioners managing patients with asthma, AR, and RS. Methods: This was a cross-sectional observational study using a questionnaire encompassing all pertinent PROMs and disseminated to practitioners associated with the ARIA, UCARE, ADCARE, and ACARE networks. Individuals unfamiliar with PROMS or lacking prior experience with it were eliminated. Descriptive and analytical data were utilized, categorized by the frequency and type of PROMs applied. Stata 18.0 was utilized, with Results: A total of 439 practitioners participated, with PROMs predominantly utilized by physicians certified for over 30 years and by respiratory specialists (16.67% and 12.46%, respectively; Conclusions: The use of PROMs is suboptimal, primarily due to time limitations. It is imperative that methods be swiftly implemented to include these techniques into the therapeutic environment to attain enhanced outcomes.

Indexed as

allergic rhinitisasthmapatient reported outcome measuresphysiciansrhinosinusitis

Identifiers

PMID42109508
PMCPMC13154597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.